Many people assume FDA considers the VALUE of new drugs as part of their drug approval process

Many people assume FDA considers the VALUE of new drugs as part of their drug approval process.

But they don't. By law, FDA only considers safety and efficacy...NOT the drug's cost or whether it's needed. FDA can't take into account whether we really need an 8th statin...or a 9th ARB.

This explains why manufacturers often try to protect their patents with new drugs that are only a slight twist on existing products.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote